BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3146150)

  • 1. Potentiation of the thrombolytic efficacy of single-chain urokinase (Pro-urokinase) by heparin.
    Gulba DC; Fischer K; Reil GH; Daniel WG; Lichtlen PR
    Thromb Haemost; 1988 Oct; 60(2):350-1. PubMed ID: 3146150
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
    Czyrski J
    Wiad Lek; 1989 Apr; 42(7):450-2. PubMed ID: 2516932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCI for totally occluded site consisting of huge thrombus.
    Oyama N; Urasawa K; Sakai H; Kitabatake A
    J Invasive Cardiol; 2003 Oct; 15(10):603-6. PubMed ID: 14519898
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolytic agents for acute evolving myocardial infarction: comparative effects.
    Sherry S
    Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasminogen activators as thrombolytic agents in myocardial infarction].
    Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations.
    Verstraete M
    Circulation; 1987 Aug; 76(2 Pt 2):II31-8. PubMed ID: 3111745
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.
    Lijnen HR; Stump DC; Collen DC
    Semin Thromb Hemost; 1987 Apr; 13(2):152-9. PubMed ID: 3114883
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
    Páramo JA; Collen D
    Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary reperfusion studies with pro-urokinase in acute myocardial infarction: evidence for synergism of low dose urokinase.
    Kasper W; Hohnloser SH; Engler H; Meinertz T; Wilkens J; Roth E; Lang K; Limbourg P; Just H
    J Am Coll Cardiol; 1990 Sep; 16(3):733-8. PubMed ID: 2117622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
    Samama M; Horellou MH; Nguyen G; Conard J
    Haemostasis; 1986; 16 Suppl 4():35-9. PubMed ID: 3095199
    [No Abstract]   [Full Text] [Related]  

  • 12. [Initial experiences with pro-urokinase in acute myocardial infarct].
    Schanzenbächer P; Huber J; Keller F; Kochsiek K
    Z Kardiol; 1987 Sep; 76(9):570-5. PubMed ID: 3122430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ; Francis CW
    Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
    [No Abstract]   [Full Text] [Related]  

  • 14. Unresolved clinical pharmacologic questions in thrombolytic therapy for acute myocardial infarction.
    Sherry S
    J Am Coll Cardiol; 1988 Aug; 12(2):519-25. PubMed ID: 3134481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences with pro-urokinase and potentiation of its fibrinolytic effect by urokinase and by tissue plasminogen activator.
    Gurewich V
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):16B-21B. PubMed ID: 3117859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic therapy in acute myocardial infarction. A perspective.
    Sherry S
    Drugs; 1987; 33 Suppl 3():1-12. PubMed ID: 2960512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis for evolving myocardial infarction. Health and Public Policy Committee, American College of Physicians.
    Ann Intern Med; 1985 Sep; 103(3):463-9. PubMed ID: 3161441
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic use of thrombolytic agents.
    Stambaugh RL; Alexander MR
    Am J Hosp Pharm; 1981 Jun; 38(6):817-24. PubMed ID: 7018230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New thrombolytic drugs].
    Kopeć M
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):127-30. PubMed ID: 2216951
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolytic therapy in patients with acute myocardial infarction.
    Rentrop KP
    Circulation; 1985 Apr; 71(4):627-31. PubMed ID: 4038632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.